75 related articles for article (PubMed ID: 6254120)
1. Hepatic insensitivity to glucagon in ob/ob mice.
Yen TT; Stamm NB; Fuller RW; Root MA
Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):29-40. PubMed ID: 6254120
[TBL] [Abstract][Full Text] [Related]
2. Sources of plasma glucose and liver glycogen in fasted ob/ob mice.
Turner SM; Linfoot PA; Neese RA; Hellerstein MK
Acta Diabetol; 2005 Dec; 42(4):187-93. PubMed ID: 16382307
[TBL] [Abstract][Full Text] [Related]
3. The effect of fasting on tissue cyclic cAMP and plasma glucagon in the obese hyperglycemic mouse.
Lavine RL; Voyles N; Perrino PV; Recant L
Endocrinology; 1975 Sep; 97(3):615-20. PubMed ID: 170069
[TBL] [Abstract][Full Text] [Related]
4. Kinetic and functional characterization of 1,4-dideoxy-1, 4-imino-d-arabinitol: a potent inhibitor of glycogen phosphorylase with anti-hyperglyceamic effect in ob/ob mice.
Fosgerau K; Westergaard N; Quistorff B; Grunnet N; Kristiansen M; Lundgren K
Arch Biochem Biophys; 2000 Aug; 380(2):274-84. PubMed ID: 10933882
[TBL] [Abstract][Full Text] [Related]
5. Effects of glucagon and insulin on fatty acid synthesis and glycogen degradation in the perfused liver of normal and genetically obese (ob/ob) mice.
Ma GY; Gove CD; Hems DA
Biochem J; 1978 Sep; 174(3):761-8. PubMed ID: 31866
[TBL] [Abstract][Full Text] [Related]
6. Modulation of basal hepatic glycogenolysis by nitric oxide.
Borgs M; Bollen M; Keppens S; Yap SH; Stalmans W; Vanstapel F
Hepatology; 1996 Jun; 23(6):1564-71. PubMed ID: 8675178
[TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.
Lee YS; Shin S; Shigihara T; Hahm E; Liu MJ; Han J; Yoon JW; Jun HS
Diabetes; 2007 Jun; 56(6):1671-9. PubMed ID: 17369525
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with novel glycogen synthase kinase-3 inhibitor improves glucose homeostasis in ob/ob mice: molecular characterization in liver and muscle.
Kaidanovich-Beilin O; Eldar-Finkelman H
J Pharmacol Exp Ther; 2006 Jan; 316(1):17-24. PubMed ID: 16169938
[TBL] [Abstract][Full Text] [Related]
9. Hormonal control of glycogenolysis in isolated chick embryo hepatocytes.
Onoagbe IO
Exp Cell Res; 1993 Nov; 209(1):1-5. PubMed ID: 8223994
[TBL] [Abstract][Full Text] [Related]
10. Increase of hepatic L-phenylalanine: pyruvate aminotransferase by glucagon in rats. Possible role of adenosine cyclic 3',5'-monophosphate as a mediator.
Fuller RW; Snoddy HD; Bromer WW
Mol Pharmacol; 1972 May; 8(3):345-52. PubMed ID: 4339289
[No Abstract] [Full Text] [Related]
11. Metabolic effect of sodium selenite: insulin-like inhibition of glucagon-stimulated glycogenolysis in the isolated perfused rat liver.
Roden M; Prskavec M; Fürnsinn C; Elmadfa I; König J; Schneider B; Wagner O; Waldhäusl W
Hepatology; 1995 Jul; 22(1):169-74. PubMed ID: 7601409
[TBL] [Abstract][Full Text] [Related]
12. Impaired glucagon-stimulated glucose output in livers of acutely uremic rats.
Perez GO; Rabinovitch A; Rietberg B; Owens B; Schiff ER
J Lab Clin Med; 1982 May; 99(5):669-77. PubMed ID: 6279748
[TBL] [Abstract][Full Text] [Related]
13. Chronic ethanol consumption lessens the gain of body weight, liver triglycerides, and diabetes in obese ob/ob mice.
Fromenty B; Vadrot N; Massart J; Turlin B; Barri-Ova N; Lettéron P; Fautrel A; Robin MA
J Pharmacol Exp Ther; 2009 Oct; 331(1):23-34. PubMed ID: 19587315
[TBL] [Abstract][Full Text] [Related]
14. Pivotal role of cAMP in the activation of liver glycogen breakdown in high-fat diet fed mice.
Schiavon FP; Marques Ade C; Carrara MA; de Souza HM; Schamber CR; Curi R; Bazotte RB
Life Sci; 2014 Jul; 109(2):111-5. PubMed ID: 24968301
[TBL] [Abstract][Full Text] [Related]
15. Chronic administration of alogliptin, a novel, potent, and highly selective dipeptidyl peptidase-4 inhibitor, improves glycemic control and beta-cell function in obese diabetic ob/ob mice.
Moritoh Y; Takeuchi K; Asakawa T; Kataoka O; Odaka H
Eur J Pharmacol; 2008 Jul; 588(2-3):325-32. PubMed ID: 18499100
[TBL] [Abstract][Full Text] [Related]
16. The effect of an acute elevation of NEFA concentrations on glucagon-stimulated hepatic glucose output.
Everett-Grueter C; Edgerton DS; Donahue EP; Vaughan S; Chu CA; Sindelar DK; Cherrington AD
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E449-59. PubMed ID: 16608886
[TBL] [Abstract][Full Text] [Related]
17. Glucagon and choleragen stimulation of glycogenolysis in primary cultures of adult rat liver parenchymal cells: lack of involvement of the glucocorticoids.
Kletzien RF; Weber CA; Butcher FR; Stumpo DJ
J Cell Physiol; 1982 Mar; 110(3):304-10. PubMed ID: 6282901
[No Abstract] [Full Text] [Related]
18. [Role of cyclic AMP in regulation of hepatic glycogen synthetase activity].
Van den Berghe G; De Wulf H; Hers HG
Arch Int Physiol Biochim; 1970 Aug; 78(3):604-6. PubMed ID: 4098031
[No Abstract] [Full Text] [Related]
19. Feedback-inhibition of glucagon-stimulated glycogenolysis in hepatocyte/Kupffer cell cocultures by glucagon-elicited prostaglandin production in Kupffer cells.
Hespeling U; Jungermann K; Püschel GP
Hepatology; 1995 Nov; 22(5):1577-83. PubMed ID: 7590678
[TBL] [Abstract][Full Text] [Related]
20. Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver.
Honda H; Ikejima K; Hirose M; Yoshikawa M; Lang T; Enomoto N; Kitamura T; Takei Y; Sato N
Hepatology; 2002 Jul; 36(1):12-21. PubMed ID: 12085344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
